LENZ Therapeutics, Inc. - Common Stock (LENZ)

CUSIP: 52635N103

Q1 2024 13F Holders as of 31 Mar 2024

Security identity
Shares outstanding
31,105,155
Holder snapshot
Share change
+16,155,534
Reported price per share
$22.33
Number of holders
54
Value change
+$360,723,016
Number of buys
53

Security key

52635N103

Report period

Q1 2024

Institutions

54

Top holders

10

Ownership snapshot

Top reported holders of LENZ - LENZ Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
EcoR1 Capital, LLC
13D/G signal
Evidence rows
15
Latest as of
21 Mar 2024
3/4/5 Highest disclosed value: $34,836,860 Showing 1-6 of 15 holder rows.
Holder Evidence Ownership % Position 12M Net Δ As of
EcoR1 Capital, LLC
3/4/5
10%+ Owner
class O/S missing
$34,836,860
8,538,446 shares
06 Jan 2023
Samsara BioCapital, L.P.
3/4/5
10%+ Owner
class O/S missing
$34,668,033
8,497,067 shares
11 Apr 2022
Versant Venture Capital VII, L.P.
3/4/5
10%+ Owner
class O/S missing
$6,523,059
1,598,789 shares
21 Mar 2024
Alpha Wave Ventures GP, Ltd
3/4/5
10%+ Owner
class O/S missing
3,612,211 shares
21 Mar 2024
Phil Gutry
3/4/5
CHIEF BUSINESS OFFICER
class O/S missing
$1,223,759
299,941 shares
11 Apr 2022
Katherine V Stultz
3/4/5
CHIEF OPERATING OFFICER
mixed-class rows
$881,362
305,954 shares
mixed-class rows
24 Jun 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
54
Shares
16,171,755
Rows available
54
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q1 2024 vs Q4 2025 Across Filers

Q4 2025 holders
161
Q1 2024 holders
54
Holder diff
-107
Investor Q4 2025 Shares Q1 2024 Shares Share Diff Share Chg % Q4 2025 value Q1 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .